Human anti-tau antibodies
US8940272B2 · kind B2 · utility
27Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 11, 2011 |
| Grant date | Jan 27, 2015 |
| Priority date | — |
| Expiry date | Mar 26, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are novel human tau-specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for tau are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for tau targeted immunotherapy and diagnosis, respectively.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.